Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | FNTA | P49354 | 2/20 | 0.36 |
| ▸ | FNTB | P49356 | 2/20 | 0.36 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 3/20 | 0.35 |
| ▸ | GNPAT | O15228 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16128209 | 0.86 | SUCNR1 (0.33) | CA2CA4FNTAFNTBSUCNR1 | |
| SCHEMBL6920799 | 0.84 | GABRR1 (0.34) | CA2CA4GNPAT | |
| SCHEMBL31365972 | 0.84 | CA2 (0.37) | CA2CA4TDP1MMEGNPAT | |
| SCHEMBL14948807 | 0.83 | TGFBR1 (0.35) | MMESMN1; SMN2 | |
| SCHEMBL28113681 | 0.80 | FOLH1 (0.52) | — | |
| SCHEMBL29599134 | 0.79 | KDM4E (0.50) | CA2MMESMN1; SMN2 | |
| SCHEMBL27813029 | 0.79 | KDM4E (0.50) | CA2MMESMN1; SMN2 | |
| SCHEMBL28371705 | 0.78 | CA2 (0.41) | CA2CA4FNTAFNTBTDP1 | |
| SCHEMBL17879530 | 0.78 | CA2 (0.41) | CA2CA4FNTAFNTBTDP1 | |
| SCHEMBL27860606 | 0.78 | CA2 (0.44) | CA2CA4TDP1MMEGNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114630835-B | Process for the preparation of peptide compounds comprising sterically bulky amino acids | 中外制药株式会社 | 2025-02-11 | — | — | CN | disclosed |